ATE291018T1 - Pyrazol verbindungen und ihre verwendung - Google Patents

Pyrazol verbindungen und ihre verwendung

Info

Publication number
ATE291018T1
ATE291018T1 AT99966665T AT99966665T ATE291018T1 AT E291018 T1 ATE291018 T1 AT E291018T1 AT 99966665 T AT99966665 T AT 99966665T AT 99966665 T AT99966665 T AT 99966665T AT E291018 T1 ATE291018 T1 AT E291018T1
Authority
AT
Austria
Prior art keywords
pyrazole compounds
same
compounds
organism
directed
Prior art date
Application number
AT99966665T
Other languages
English (en)
Inventor
Bradley B Brown
Patrick J Casey
Zita Latona
Casey Pritchard Purdy
Sarah Tavares
Original Assignee
Ppd Discovery Inc
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ppd Discovery Inc, Univ Duke filed Critical Ppd Discovery Inc
Application granted granted Critical
Publication of ATE291018T1 publication Critical patent/ATE291018T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
AT99966665T 1998-12-24 1999-12-21 Pyrazol verbindungen und ihre verwendung ATE291018T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11394898P 1998-12-24 1998-12-24
US09/440,209 US6191147B1 (en) 1998-12-24 1999-11-15 Pyrazole compounds and uses thereof
PCT/US1999/030951 WO2000039083A2 (en) 1998-12-24 1999-12-21 Pyrazole compounds and uses thereof

Publications (1)

Publication Number Publication Date
ATE291018T1 true ATE291018T1 (de) 2005-04-15

Family

ID=26811662

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99966665T ATE291018T1 (de) 1998-12-24 1999-12-21 Pyrazol verbindungen und ihre verwendung

Country Status (8)

Country Link
US (1) US6191147B1 (de)
EP (1) EP1140900B1 (de)
JP (1) JP2002533436A (de)
AT (1) ATE291018T1 (de)
AU (2) AU772943B2 (de)
CA (1) CA2359462C (de)
DE (1) DE69924292T2 (de)
WO (1) WO2000039083A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60112742T2 (de) 2000-05-19 2006-02-02 Applied Research Systems Ars Holding N.V. Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
AU2002349621A1 (en) * 2001-11-30 2003-06-10 Santen Pharmaceutical Co., Ltd. Angiogenesis inhibitor
US6649638B1 (en) * 2002-08-14 2003-11-18 Ppd Discovery, Inc. Prenylation inhibitors and methods of their synthesis and use
EP1534279A4 (de) * 2002-08-14 2006-11-08 Ppd Discovery Inc Prenylierungshemmer mit dimethyl-cyclobutan und verfahren zu ihrer synthese und verwendung
AU2003265395A1 (en) * 2002-08-14 2004-03-03 Ppd Discovery, Inc. Prenylation inhibitors and methods of their synthesis and use
JP4691041B2 (ja) 2003-11-20 2011-06-01 チルドレンズ ホスピタル メディカル センター Gtpアーゼ阻害剤および使用方法
US6799739B1 (en) * 2003-11-24 2004-10-05 The Boeing Company Aircraft control surface drive system and associated methods
AU2006275528B2 (en) 2005-07-29 2012-03-08 Children's Hospital Medical Center GTPase inhibitors and methods of use and crystal structure of Rac-1 GTPase
EP1939181A1 (de) * 2006-12-27 2008-07-02 sanofi-aventis Heteroaryl-substituierte Carboxamide und deren Verwendung für die Stimulierung der NO Synthase Expression
TWI448284B (zh) * 2007-04-24 2014-08-11 Theravance Inc 雙效抗高血壓劑
AU2008286760A1 (en) * 2007-08-15 2009-02-19 Memory Pharmaceuticals Corporation 3' substituted compounds having 5-HT6 receptor affinity
US20110009463A1 (en) * 2007-10-17 2011-01-13 Yuri Karl Petersson Geranylgeranyl transferase inhibitors and methods of making and using the same
US20110201649A1 (en) * 2008-09-19 2011-08-18 Sumitomo Chemical Company, Limited agricultural composition
FR2949463B1 (fr) * 2009-08-26 2011-09-16 Commissariat Energie Atomique Inhibiteurs de mmp
WO2011161645A1 (en) 2010-06-25 2011-12-29 Ranbaxy Laboratories Limited 5-lipoxygenase inhibitors
WO2012003405A1 (en) 2010-06-30 2012-01-05 Ironwood Pharmaceuticals, Inc. Sgc stimulators
NZ609955A (en) 2010-11-09 2015-05-29 Ironwood Pharmaceuticals Inc Sgc stimulators
CN104066731B (zh) 2011-12-27 2016-06-15 铁木医药有限公司 可用作sgc刺激剂的2-苄基、3-(嘧啶-2-基)取代的吡唑类
US9980942B2 (en) 2012-05-02 2018-05-29 Children's Hospital Medical Center Rejuvenation of precursor cells
US10028503B2 (en) 2014-06-18 2018-07-24 Children's Hospital Medical Center Platelet storage methods and compositions for same
EP4013402B1 (de) 2019-08-16 2024-11-06 Children's Hospital Medical Center Cdc-42-inhibitoren zur verwendung bei der behandlung von altersverbundener depression, sarkopenie oder gebrechlichkeit
CN111961048B (zh) * 2020-08-26 2022-05-13 南通大学 含取代β-咔啉结构的三氟甲基吡唑酰胺及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164381A (en) 1986-05-29 1992-11-17 Ortho Pharmaceutical Corporation Pharmacologically active 1,5-diaryl-3-substituted pyrazoles and method for synthesizing the same
US4826868A (en) 1986-05-29 1989-05-02 Ortho Pharmaceutical Corporation 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
FR2665898B1 (fr) 1990-08-20 1994-03-11 Sanofi Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
DE4414974A1 (de) 1994-04-29 1995-11-02 Bayer Ag Substituierte Pyrazolinderivate
WO1997005902A1 (fr) * 1995-08-09 1997-02-20 Banyu Pharmaceutical Co., Ltd. Composition medicinale
US5633388A (en) 1996-03-29 1997-05-27 Viropharma Incorporated Compounds, compositions and methods for treatment of hepatitis C
DE19623892A1 (de) 1996-06-06 1997-12-11 Hoechst Schering Agrevo Gmbh Substituierte Pyrazolyl-pyrazolderivate
JP2002508754A (ja) 1997-05-22 2002-03-19 ジー ディ サール アンド カンパニ p38キナーゼ阻害剤としての置換基を有するピラゾール類

Also Published As

Publication number Publication date
AU772943B2 (en) 2004-05-13
WO2000039083A3 (en) 2000-11-02
EP1140900B1 (de) 2005-03-16
AU2216600A (en) 2000-07-31
DE69924292T2 (de) 2006-04-13
WO2000039083A2 (en) 2000-07-06
CA2359462C (en) 2010-07-06
DE69924292D1 (de) 2005-04-21
US6191147B1 (en) 2001-02-20
CA2359462A1 (en) 2000-07-06
EP1140900A2 (de) 2001-10-10
JP2002533436A (ja) 2002-10-08
EP1140900A4 (de) 2002-04-10
AU2004202912A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
DE69924292D1 (de) Pyrazol verbindungen und ihre verwendung
ATE219765T1 (de) Indolderivate als cgmp-pde inhibitoren
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
TR200200778T2 (tr) Pirazol türevleri.
EA200300248A1 (ru) Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции
ATE228507T1 (de) Substituierte 6-phenylphenanthridine
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
MY126862A (en) Purine derivatives inhibitors of tyrosine protein kinase syk
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
DK0738270T3 (da) Dihydropyrazolopyrroler
TR200102338T2 (tr) Siklik ikame edilmiş bağlı pirolokarbazoller ve izoindolonlar.
AP1246A (en) Substituted pyrazoles as p38 Kinase inhibitors.
DE69718194D1 (de) Amidinophenyl-pyrrolidine, -pyrroline und -isoxazolidine und ihre derivate
BG100069A (bg) Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им
ATE495187T1 (de) Dalda-analoge und ihre verwendung
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
TR200103789T2 (tr) Tirozin kinaz inhibitörleri olarak ikameli 1,4-dihidroindeno[1,2-C]pirazoller.
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
DE69330601D1 (de) Serotoninergische ergolin derivate
SE9504662D0 (sv) New compounds
AP2000001760A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
AP2002002595A0 (en) Heterocyclic amide derivatives.
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties